Reuters logo
BRIEF-Redhill Biopharma prices concurrent public offering, registered direct offering of its ADS, Warrants
December 21, 2016 / 2:29 PM / a year ago

BRIEF-Redhill Biopharma prices concurrent public offering, registered direct offering of its ADS, Warrants

Dec 21 (Reuters) - Redhill Biopharma Ltd :

* Warrants in both offerings will have a per ads exercise price of $13.33, and have a term of three years

* Price in both offerings is $10.25 for a fixed combination of one ads and a warrant to purchase 0.5 of an ADS

* Intends to use proceeds from both offerings to fund clinical development programs, for potential acquisitions

* Redhill Biopharma prices concurrent public offering and registered direct offering of its American depositary shares and warrants Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below